Cargando…
Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749053/ https://www.ncbi.nlm.nih.gov/pubmed/19732456 http://dx.doi.org/10.1186/1471-2180-9-189 |
_version_ | 1782172160972816384 |
---|---|
author | Maor, Yasmin Lago, Levona Zlotkin, Amir Nitzan, Yeshayahu Belausov, Natasha Ben-David, Debby Keller, Nathan Rahav, Galia |
author_facet | Maor, Yasmin Lago, Levona Zlotkin, Amir Nitzan, Yeshayahu Belausov, Natasha Ben-David, Debby Keller, Nathan Rahav, Galia |
author_sort | Maor, Yasmin |
collection | PubMed |
description | BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin sensitive S. aureus (MSSA) blood isolates. RESULTS: We assessed phenotypic and genomic changes of hVISA (n = 24), MRSA (n = 16) and MSSA (n = 17) isolates by PCR to determine staphylococcal chromosomal cassette (SCCmec) types, Panton-Valentine leukocidin (PVL) and the accessory gene regulator (agr) loci. Biofilm formation was quantified. Genetic relatedness was assessed by PFGE. PFGE analysis of isolates was diverse suggesting multiple sources of infection. 50% of hVISA isolates carried SCCmec type I, 21% type II; 25% type V; in 4% the SCCmec type could not be identified. Among MRSA isolates, 44% were SCCmec type I, 12.5% type II, 25% type V, 12.5% were non-typable, and 6% were SCCmec type IVd. Only one hVISA isolate and two MSSA isolates carried the PVL. Biofilm formation and agr patterns were diverse. CONCLUSION: hVISA isolates were diverse in all parameters tested. A considerable number of hVISA and MRSA strains carried the SCCmec type V cassette, which was not related to community acquisition. |
format | Text |
id | pubmed-2749053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27490532009-09-23 Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients Maor, Yasmin Lago, Levona Zlotkin, Amir Nitzan, Yeshayahu Belausov, Natasha Ben-David, Debby Keller, Nathan Rahav, Galia BMC Microbiol Research article BACKGROUND: Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) bacteremia is an emerging infection. Our objective was to determine the molecular features of hVISA strains isolated from bacteremic patients and to compare them to methicillin resistant S. aureus (MRSA) and methicillin sensitive S. aureus (MSSA) blood isolates. RESULTS: We assessed phenotypic and genomic changes of hVISA (n = 24), MRSA (n = 16) and MSSA (n = 17) isolates by PCR to determine staphylococcal chromosomal cassette (SCCmec) types, Panton-Valentine leukocidin (PVL) and the accessory gene regulator (agr) loci. Biofilm formation was quantified. Genetic relatedness was assessed by PFGE. PFGE analysis of isolates was diverse suggesting multiple sources of infection. 50% of hVISA isolates carried SCCmec type I, 21% type II; 25% type V; in 4% the SCCmec type could not be identified. Among MRSA isolates, 44% were SCCmec type I, 12.5% type II, 25% type V, 12.5% were non-typable, and 6% were SCCmec type IVd. Only one hVISA isolate and two MSSA isolates carried the PVL. Biofilm formation and agr patterns were diverse. CONCLUSION: hVISA isolates were diverse in all parameters tested. A considerable number of hVISA and MRSA strains carried the SCCmec type V cassette, which was not related to community acquisition. BioMed Central 2009-09-04 /pmc/articles/PMC2749053/ /pubmed/19732456 http://dx.doi.org/10.1186/1471-2180-9-189 Text en Copyright ©2009 Maor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research article Maor, Yasmin Lago, Levona Zlotkin, Amir Nitzan, Yeshayahu Belausov, Natasha Ben-David, Debby Keller, Nathan Rahav, Galia Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title_full | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title_fullStr | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title_full_unstemmed | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title_short | Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients |
title_sort | molecular features of heterogeneous vancomycin-intermediate staphylococcus aureus strains isolated from bacteremic patients |
topic | Research article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749053/ https://www.ncbi.nlm.nih.gov/pubmed/19732456 http://dx.doi.org/10.1186/1471-2180-9-189 |
work_keys_str_mv | AT maoryasmin molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT lagolevona molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT zlotkinamir molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT nitzanyeshayahu molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT belausovnatasha molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT bendaviddebby molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT kellernathan molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients AT rahavgalia molecularfeaturesofheterogeneousvancomycinintermediatestaphylococcusaureusstrainsisolatedfrombacteremicpatients |